Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529

This publication has 19 references indexed in Scilit:

• The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane)
  Inflammation Research, 1990
• Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the rat
  Toxicology and Applied Pharmacology, 1990
• Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer
  New England Journal of Medicine, 1988
• Cytofluorescence localization and disposition of doxorubicin and doxorubicinol in rat cardiac tissue
  European Journal of Cancer and Clinical Oncology, 1988
• Protective effect of ICRF-187 on doxorubicin-induced cardiac and renal toxicity in spontaneously hypertensive (SHR) and normotensive (WKY) rats
  Toxicology and Applied Pharmacology, 1988
• Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat
  Journal of Pharmacological Methods, 1986
• Pretreatment with ICRF-187 provides long-lasting protection against chronic daunorubicin cardiotoxicity in rabbits
  Cancer Chemotherapy and Pharmacology, 1986
• Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogs
  The American Journal of Cardiology, 1985
• Acute effects of doxorubicin (adriamycin) on left ventricular function in dogs
  International Journal of Cardiology, 1984
• Solution chemistry studies of adriamycin-iron complexes present in vivo
  Published by Elsevier ,1980